Riskpilot← Back to searchSign inGet full accessKiuru Medical Oy
OYDissolvedY-tunnus 3174147-7Kulosaarentie 22Medical specialists activities · NACE 8622Est. 2020— employees
Revenue 2025
EUR 769K
-4% vs 2024
EBITDA margin
10.0%
-95% vs 2024
Equity ratio
94.7%
Financial strength
Net profit 2025
EUR 60K
+17% vs 2024
| Revenue | EUR 769K | -4% |
| EBITDA | EUR 77K | -95% |
| Net profit | EUR 60K | +17% |
| Total assets | EUR 252K | +27% |
| Equity | EUR 238K | +23% |
| Employees | — | — |
Legal name
Kiuru Medical Oy
Y-tunnus number
3174147-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
30. marraskuuta 2020
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Yhtiön toimiala on erikoislääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen, luennointi sekä kustannustoiminta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Kulosaarentie 22
Phone
+3580440705223
Email
mia.kiuru@terveystalo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 249 | 575 | 737 | 801 | 769 |
| Staff expenses | −25 | −105 | −148 | 148 | −154 |
| EBITDA | 60 | 71 | 80 | 1 537 | 77 |
| Depreciation & amort. | −0 | −0 | −2 | 1 | −2 |
| EBIT | 59 | 71 | 78 | 65 | 75 |
| Net financials | 0 | — | −0 | — | — |
| Profit before tax | 59 | 71 | 78 | 64 | 75 |
| Tax | 12 | 14 | 16 | 13 | −15 |
| Net profit | 48 | 57 | 62 | 51 | 60 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 63 | 106 | 167 | 198 | 252 |
| Equity | 48 | 100 | 155 | 194 | 238 |
| Long-term debt | — | — | 0 | — | — |
| Short-term debt | 15 | 6 | 12 | 4 | 13 |
| Total debt | 15 | 6 | 12 | 4 | 13 |
EBITDA margin
10.0%
This company
15.8%
Market median
-37% vs market
20212025
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
25.2%
This company
18.4%
Market median
+37% vs market
20212025
Net profit margin
7.8%
This company
8.1%
Market median
-4% vs market
20212025
Asset turnover
3.06×
This company
1.12×
Market median
+173% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-11-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MS Chief Executive Officer | Chief Executive Officer | 2020 |
UK Deputy Member | Deputy Member | 2020 |
JA Deputy auditor | Deputy auditor | 2024 |
KK Audit | Audit | 2024 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kiuru Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mia Susanna Kiuru | Chief Executive Officer | 0 companies |
| Ulla-Mari Kiuru | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Deputy auditor | 0 companies |
| Kiri Kasperi Sopanen | Audit | 0 companies |